Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026

Go back to Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026
(NASDAQ: LYEL) Delayed: 11.61 -0.88 (7.05%)
Previous Close $12.49    52 Week High
Open $12.38    52 Week Low
Day High $12.68    P/E N/A 
Day Low $11.47    EPS
Volume 1,574,434